Atlas Trials

Recurrent Esophageal Cancer

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Esophageal Cancer

RecordFirmDate
Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection (NCT01249443)AIDS Malignancy Consortium2013-11-01
Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery (NCT01612546)City of Hope Medical Center2012-11-01
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery (NCT01705340)National Cancer Institute (NCI)2012-09-01
Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer (NCT01231399)City of Hope Medical Center2012-02-01
Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy (NCT01129206)Ohio State University Comprehensive Cancer Center2010-07-01
European iNvestigation of SUrveillance After Resection for Esophageal Cancer (NCT03461341)St. James's Hospital, Ireland2009-06-01
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384)National Cancer Institute (NCI)2007-01-01
FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer (NCT00098527)National Cancer Institute (NCI)2004-10-01
3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction (NCT00077545)National Cancer Institute (NCI)2004-01-01
Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer (NCT00045526)National Cancer Institute (NCI)2002-06-01
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681)National Cancer Institute (NCI)2001-12-01
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498)National Cancer Institute (NCI)2001-12-01
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074)National Cancer Institute (NCI)1999-08-01

Track Recurrent Esophageal Cancer automatically

Every clearance here is in the API, with alerts when new ones post.